Malignant Thymoma — Trials

Malignant Thymoma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03968315	An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma	active not recruiting	N/A	40	M.D. Anderson Cancer CenterOTHER	1	Sep 18, 2026	clinicaltrials
NCT03134118	Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)(NIVOTHYM)	active not recruiting	Phase 2	55	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	6	May 15, 2026